Publication | Closed Access

A nanoparticle formulation reduces the corneal toxicity of indomethacin eye drops and enhances its corneal permeability

NanomedicineIndomethacin Eye DropsOphthalmologyCorneal DystrophyMedicineCorneal PermeabilityPharmaceutical NanotechnologyTopical DrugAqueous HumourOcular PharmacologyPharmacologyNanoparticle Formulation